Plain-English translation of NCT07723560 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is collecting information about how people with hemophilia A (an inherited bleeding disorder) are cared for during surgery when using Altuvoct, a newer medication that helps blood clot. Researchers want to understand how well this medication works in real surgical settings and compare it with another similar treatment. The goal is to figure out the best way to use this medication to keep patients safe during operations.
Although this medication has been approved and is already being used, doctors don't yet have enough real-world information about the best way to use it during surgery. By collecting data from multiple hospitals, researchers hope to develop clearer guidelines that will help all hospitals manage hemophilia A patients more safely and consistently during operations.
You likely qualify if…
You likely don't qualify if…
If you join this study, researchers will collect information from your medical records about your surgery and how you were treated before, during, and after the operation. This includes details like how many doses of medication you received, how long you stayed in the hospital, and when you returned to your regular treatment routine. There are no additional visits or procedures — the study simply tracks your normal surgical care.
AI-generated summary from trial data · Aug 1, 2026 · Not medical advice
France
Enrollment target
~160 participants
Started
January 2026
Primary completion
March 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Last updated on clinicaltrials.gov in July 2026.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.